Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Atrium Therapeutics issued inducement equity grants under its 2026 Employment Inducement Incentive Award Plan to one newly hired non-executive employee. The award comprises non-qualified stock options for 9,500 shares at an exercise price of $7.98 and RSUs for 4,750 shares, both with four-year standard vesting schedules.
Key figures
- Rsu shares
- 4750
- Options shares
- 9500
- Option exercise price
- 7.98
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.